4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-18-043905
Options or other derivatives
- EVP, Head of Immunology acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chaparro Rodolfo EVP, Head of Immunology | 2018-07-23 | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…